Page last updated: 2024-08-24

harmol and Debility

harmol has been researched along with Debility in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ballesteros-Gonzalez, Á; Costa-Machado, LF; Del Pino, I; Duerr, JS; Eisenberg, T; Fabregat-Safont, D; Fernandez-Marcos, PJ; Fornari, T; Galindo, MI; Garcia-Dominguez, E; Gomez, J; Gomez-Cabrera, MC; Herradon, G; Hofer, SJ; Houtkooper, RH; Lopez-Aceituno, JL; Loza, MI; Madeo, F; Magnes, C; McIntyre, RL; Megias, D; Perez, M; Plaza, A; Pozo, OJ; Sierra-Ramirez, A; Tapia-Gonzalez, A; Villanueva-Bermejo, D; Viña, J1

Other Studies

1 other study(ies) available for harmol and Debility

ArticleYear
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models.
    Nature communications, 2023, 05-15, Volume: 14, Issue:1

    Topics: Adipose Tissue, Brown; Aging; AMP-Activated Protein Kinase Kinases; Animals; Antidepressive Agents; Caenorhabditis elegans; Drosophila melanogaster; Fatty Liver; Female; Frailty; Glucose Intolerance; Harmine; Insulin Resistance; Liver; Longevity; Male; Mice; Mitochondria; Mitophagy; Models, Animal; Monoamine Oxidase; Muscle Fibers, Skeletal; Muscle, Skeletal; Physical Conditioning, Animal; Prediabetic State; Receptors, GABA-A

2023